Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integral Molecular’s technologies have enabled over 600 companies to advance therapeutic discovery against difficult membrane protein targets. Their tools have contributed to new therapies for cancer, diabetes, autoimmune disorders and viral threats such as SARS-CoV‑2. They do not themselves market approved therapeutics but provide critical reagents and services that support drug/vaccine R&D pipelines globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integral Molecular.